ANGELA THOMAS: Open Payments
NPI 1265107049 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,345 in 100 payments from 34 companies in 2025. Trend: 2023 $66 · 2024 $2,518 · 2025 $2,345
Food & beverage: $2,325Education: $20
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 4 | $223 |
| ABBVIE INC. | 6 | $215 |
| Janssen Biotech, Inc. | 10 | $204 |
| AstraZeneca Pharmaceuticals LP | 8 | $197 |
| Daiichi Sankyo Inc. | 12 | $188 |
| Merck Sharp & Dohme LLC | 8 | $159 |
| Genmab U.S., Inc. | 5 | $124 |
| Incyte Corporation | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
Products named: PRECISETUMOR, ELAHERE, Enhertu, KEYTRUDA, IMFINZI, KISQALI, JAKAFI, Epkinly.
Industry payments across TX — which companies pay providers there.
